Hot Investor Mandate 4: USA and China-Based Biotech Company Seeks to Invest in Life Science Companies, with Focus on Cell/Gene Therapies, Antibodies, Synthetic Biology, etc.

5 Apr

A public biotech company with headquarters in USA and China is actively seeking for investment, partnering and acquisition opportunities to expand the company’s business in multiple areas. The firm usually invests as a strategic investor in as early as seed rounds. Typical allocations are $1-5 M.

The firm’s sectors of focus are cell and gene therapies, antibody therapeutics, life science tools, drug discovery technologies, synthetic biology technologies and industrial enzyme products.

The firm may seek a board seat depending upon size of investment. The firm is open to working with all stages of management teams and may lead or co-invest.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: